Raymond James Financial Inc. Purchases Shares of 17,893 Fresenius Medical Care AG (NYSE:FMS)

Raymond James Financial Inc. bought a new stake in Fresenius Medical Care AG (NYSE:FMS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 17,893 shares of the company's stock, valued at approximately $405,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in FMS. Assetmark Inc. raised its holdings in Fresenius Medical Care by 196.3% during the fourth quarter. Assetmark Inc. now owns 7,210 shares of the company's stock worth $163,000 after acquiring an additional 4,777 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Fresenius Medical Care by 40.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 31,074 shares of the company's stock valued at $704,000 after purchasing an additional 8,913 shares during the last quarter. Jones Financial Companies Lllp increased its stake in shares of Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock worth $102,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC lifted its holdings in shares of Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after buying an additional 806 shares in the last quarter. Finally, US Bancorp DE raised its stake in Fresenius Medical Care by 8.6% in the 4th quarter. US Bancorp DE now owns 20,429 shares of the company's stock worth $463,000 after purchasing an additional 1,610 shares in the last quarter. 8.37% of the stock is owned by institutional investors.

Remove Ads

Fresenius Medical Care Trading Up 0.6 %

Fresenius Medical Care stock traded up $0.14 during trading hours on Friday, reaching $23.96. 325,143 shares of the company's stock were exchanged, compared to its average volume of 318,835. The firm's 50 day simple moving average is $23.94 and its 200 day simple moving average is $22.79. Fresenius Medical Care AG has a twelve month low of $17.93 and a twelve month high of $25.96. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $14.06 billion, a PE ratio of 19.80, a PEG ratio of 0.76 and a beta of 0.93.

Analysts Set New Price Targets

A number of research firms have commented on FMS. StockNews.com upgraded Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. Truist Financial boosted their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Monday, January 6th.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.